Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Fludarabine-Cyclophosphamide Regimen

Known as: CF Regimen, FC Regimen, Flu-Cy Regimen 
A regimen consisting of fludarabine and cyclophosphamide used as initial treatment for chronic lymphocytic leukemia (CLL); also used for the… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Chronic lymphocytic leukaemia (CLL) is the most common adult leukaemia in Europe and North America. The disease is characterized… Expand
  • table I
  • table II
  • table III
Is this relevant?
2012
2012
The aim of this study was to evaluate the therapeutic effects and adverse reactions of fludarabine-based regimen for patients… Expand
Is this relevant?
2011
2011
OBJECTIVES We evaluated the cost-effectiveness of rituximab added to the chemotherapy regimen of fludarabine plus… Expand
Is this relevant?
2011
2011
Objetivos: Evaluar el coste-efectividad del esquema de rituximab, fludarabina y ciclofosfamida (R-FC) en comparacion con el de… Expand
Is this relevant?
Review
2010
Review
2010
Over the last few years, several monoclonal antibodies have been investigated in patients with B-cell lymphoid malignancies… Expand
Is this relevant?
2010
2010
Therapy related myelodysplastic syndrome (t-MDS) and secondary acute myeloid leukemia (AML) are seriously late complications of… Expand
Is this relevant?
Review
2009
Review
2009
This article contains data review of comparative assessment of "cost-effectiveness" rate of R-FC (rituximab, fludarabin… Expand
Is this relevant?
2008
2008
  • C. Nabhan
  • Clinical Cancer Research
  • 2008
  • Corpus ID: 35909770
To the Editor: I would like to congratulate Bosch and colleagues on a well-conducted clinical investigation confirming the… Expand
Is this relevant?
2003
2003
PurposeAmifostine is an organic thiophosphate that may selectively protect normal tissues from the toxicities of chemotherapy… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
1995
1995
With the aim of increasing complete response rates and improving survival in cisplatin (CDDP)-based combinations (CDDP + 5… Expand
Is this relevant?